UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma

Brazilian journal of otorhinolaryngology, 2020-11, Vol.86 (6), p.676-686

2020

Volltextzugriff (PDF)

The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer

Journal of oncology pharmacy practice, 2020-12, Vol.26 (8), p.1878-1885

2020

Volltextzugriff (PDF)

The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas

Hitit medical journal, 2024-02, Vol.6 (1), p.71-78

2024

Volltextzugriff (PDF)

Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients

Asian Pacific journal of cancer prevention : APJCP, 2014-01, Vol.15 (15), p.6449-6453

2014

Volltextzugriff (PDF)

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer

Medical oncology (Northwood, London, England), 2014-01, Vol.31 (1), p.801-801, Article 801

2014

Volltextzugriff (PDF)

Hormone receptor status and survival of medullary breast cancer patients

Saudi medical journal, 2017-02, Vol.38 (2), p.156-162

2017

Volltextzugriff (PDF)

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer

Asian Pacific journal of cancer prevention : APJCP, 2014-01, Vol.15 (21), p.9277-9281

2014

Volltextzugriff (PDF)

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?

Clinical genitourinary cancer, 2015-12, Vol.13 (6), p.548-554

2015

Volltextzugriff (PDF)

Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Thoracic cancer, 2015-01, Vol.6 (1), p.85-90

2015

Volltextzugriff (PDF)

Clinicopathological features of patients with ovarian and breast cancer with BRCA mutation

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13524-e13524

2020

Volltextzugriff (PDF)

Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer

Clinical lung cancer, 2023-05, Vol.24 (3), p.252-259

2023

Volltextzugriff (PDF)

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e20512-e20512

2024

Volltextzugriff (PDF)

Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer pati̇ents treated with erlotinib

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21217-e21217

2018

Volltextzugriff (PDF)

Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2019-09, Vol.24 (5), p.1861

2019

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15562-e15562

2022

Volltextzugriff (PDF)

Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer

Future oncology (London, England), 2021-11, Vol.17 (31), p.4157-4169

2021

Volltextzugriff (PDF)

Cardiac Tamponade Induced by Malignancy-Associated Chylopericardium

Türk Kardiyoloji Derneği arşivi, 2023, p.429-430

Biçer, Nazmiye Serap

2023

Volltextzugriff (PDF)

Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?

Journal of oncology pharmacy practice, 2020-06, Vol.26 (4), p.781-786

2020

Volltextzugriff (PDF)

The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2019-09, Vol.24 (5), p.1992

2019

Volltextzugriff (PDF)

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer

International journal of gynecological cancer, 2022-04, Vol.32 (4), p.502-507

2022

Volltextzugriff (PDF)

Impact of prognostic factors on platinum response in extrapulmonary neuroendocrine carcinoma

Annals of Clinical and Analytical Medicine, 2023-10, Vol.14 (Suppl_03)

2023

Volltextzugriff (PDF)

Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab

Asian Pacific journal of cancer prevention : APJCP, 2015-09, Vol.16 (14), p.6149-6154

2015

Volltextzugriff (PDF)

Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients

Journal of B.U. ON., 2015-11, Vol.20 (6), p.1432-1439

2015

Volltextzugriff (PDF)

Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients

Asian Pacific journal of cancer prevention : APJCP, 2015-04, Vol.16 (7), p.3015-3021

2015

Volltextzugriff (PDF)

The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy

Annals of medical research, 2019-10, Vol.26 (10), p.2089

2019

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma

The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer

The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas

Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer

Hormone receptor status and survival of medullary breast cancer patients

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?

Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Clinicopathological features of patients with ovarian and breast cancer with BRCA mutation

Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer pati̇ents treated with erlotinib

Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer

Cardiac Tamponade Induced by Malignancy-Associated Chylopericardium

Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?

The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study

Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer

Impact of prognostic factors on platinum response in extrapulmonary neuroendocrine carcinoma

Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab

Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients

Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients

The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy

Suchergebnisse filtern